Navigation Links
Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2008 Results
Date:3/12/2009

NANJING, China, March 12 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group ("Simcere" or the "Company') (NYSE: SCR), a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product Endu in China, today reported unaudited financial results for the quarter and fiscal year ended December 31, 2008.

    Highlights

    -- Total revenue increased to RMB 466.9 million (US$68.4 million) for the
       fourth quarter of 2008, representing 17.1% year-over-year growth; for
       the full year of 2008, total revenue was RMB 1,741.1 million (US$255.2
       million), an increase of 27.2% from RMB 1,368.7 million for the full
       year of 2007;
    -- Income from operations was RMB 72.7 million (US$10.6 million) for the
       fourth quarter of 2008, compared to RMB 73.2 million for the
       corresponding period in 2007. For the full year of 2008, operating
       income was RMB 357.0 million (US$52.3 million), an increase of 35.3%
       from RMB 263.9 million for the full year of 2007;
    -- Net income was RMB 51.7 million (US$7.6 million) for the fourth quarter
       of 2008, representing 33.8% year-over-year decrease; for the full year
       of 2008, net income was RMB 350.2 million (US$ 51.3 million), an
       increase of 16.2% from RMB 301.3 million for the full year of 2007;
    -- Gross margin for the fourth quarter of 2008 increased to 83.1%,
       compared to 82.2% for the corresponding period in 2007. For the full
       year of 2008, gross margin was 81.6%, compared to 82.4% in 2007.

Mr. Jinsheng Ren, Chairman and Chief Executive Officer of Simcere Pharmaceutical Group, commented: "We are pleased that Simcere achieved overall steady growth in 2008. While the sales growth of Endu has remained below our expectations, both Bicun and Y
'/>"/>

SOURCE Simcere Pharmaceutical Group
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Simcere Pharmaceutical Group to Announce 2008 Fourth Quarter and Full Year Earnings On Thursday, March 12, 2009
2. Simcere Pharmaceutical Group Announces Preliminary Full Year Revenue and Earnings
3. Simcere Pharmaceutical Group to Participate in Morgan Stanley Seventh Annual Asia Pacific Summit 2008
4. Simcere Pharmaceutical Group Reports Unaudited Third Quarter 2008 Results and Announces Share Repurchase
5. Simcere Pharmaceutical Group to Announce Third Quarter 2008 Earnings on Thursday, November 6, 2008
6. Simcere Pharmaceutical Group Announces Two Senior Promotions and Appointment of New Vice President of Human Resources
7. Simcere Pharmaceutical Group to Announce Second Quarter 2008 Earnings on Tuesday, August 5, 2008
8. Simcere Pharmaceutical Group to Participate in Upcoming Investor Conferences in New York
9. Simcere Pharmaceutical Group to Participate in Credit Suisse 3rd Annual Healthcare Trip
10. Simcere Pharmaceutical Group Reports Proposed Private Sale of Ordinary Shares by Existing Shareholder
11. Simcere Pharmaceutical Group Announces the Appointment of New Vice President of Marketing and Two Senior Promotions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... May 24, 2013 Vestiage, Inc. ... company focused on science-based research and development, sales ... cosmeceuticals and nutraceuticals, announced today that it is ... for the sale of Reluma Skin Illuminating Facial ... and application by sending an email to info(at)vestiageinc(dot)com ...
(Date:5/23/2013)... 2013 Venaxis, Inc. (Nasdaq:   APPY), an ... FDA clearance and commercializing its rapid, protein biomarker-based appendicitis ... an underwritten public offering of 10,000,000 shares of its ... of its common stock at an exercise price of ... of $1.25 per share and related warrant.  Venaxis has ...
(Date:5/23/2013)... 23, 2013 Patheon Inc ., ... to the global pharmaceutical industry, will host a complimentary ... to Testing” on Tuesday, June 4, 2013 at 11 ... are required to comply with regulations for cleaning validation. ... limited scientific underpinning and little evaluation of risk. ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 PI’s ... wide and provide 15 mm travel range with ... The small dimensions make these new positioners the ... spaces. A vacuum rated version is also available. ... specifications and datasheets can be found at: , ...
Breaking Biology Technology:Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 3Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 4Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 5Venaxis Announces Pricing of Offering of Common Stock and Warrants 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 3Patheon to Present on “Cleaning Validation: Science, Risk and Novel Approaches to Testing” 2Precision Positioning System Uses Miniaturezed Piezo Linear Motor: LPS-24 Linear Stage by PI 2
... 2011 Orexigen ® Therapeutics, Inc. (Nasdaq: ... on the treatment of obesity, today announced that ... Morgan Healthcare Conference. The details are as follows: ... Pacific TimeLocation:  Westin St. Francis Hotel, San Francisco, ...
... Group, Inc. (OTC Bulletin Board: BONU ), ... has received correspondence from KHA Solutions Group following a ... Group, a for-profit entity and a wholly owned subsidiary ... into BioNeutral and its products, BioNeutral may be selected ...
... 2011 Cellular Dynamics International, Inc. (CDI), the world,s ... lines and tissue cells for drug discovery and safety, ... at the 29th Annual JPMorgan Healthcare Conference at 7:30 ... Francis Hotel in San Francisco. Robert Palay, chief executive ...
Cached Biology Technology:Kentucky Hospital Association Solutions Group Outlines Next Steps for BioNeutral Partnership 2Kentucky Hospital Association Solutions Group Outlines Next Steps for BioNeutral Partnership 3
(Date:5/23/2013)... Rollins School of Public Health at Emory University, ... Technology, have received a $4 million grant over ... Emory University (Health and Exposome Research Center: Understanding ... center grant awarded in the United States. ... National Institute of Environmental Health Sciences (NIEHS) of ...
(Date:5/23/2013)... wrapping of genomic DNA around nucleosomes in the ... A team of Ludwig-Maximilians-Universitaet (LMU) in Munich now ... be locally displaced from nucleosomes for transcription. , ... in the cell nucleus, wrapped around disk-shaped particles ... four different histone proteins and accommodating two loops ...
(Date:5/23/2013)... undergo surgery or harsh treatments because science fails ... forms of the disease. Researchers at Case Western ... developing technology that allows patients to safely choose ... or take drastic measures. , The project is ... of biomedical engineering at Case Western Reserve and ...
Breaking Biology News(10 mins):Emory, Georgia Tech receive first human exposome center grant in US 2Emory, Georgia Tech receive first human exposome center grant in US 3Biochemistry: Unspooling DNA from nucleosomal disks 2Using big data to identify prostate cancers and best treatments 2Using big data to identify prostate cancers and best treatments 3
... December 2, 2010 -- Intense, individually tailored dietary treatment ... mortality, according to a new study by researchers at ... just published in the prestigious Journal of the ... months after discharge (11.6 percent) of the control group ...
... year, dengue fever infects as many as 100 million people ... Both diseases are spread by infected female Aedes ... The blood feeding and the egg development are tightly linked ... a team of entomologists at the University of California, Riverside ...
... cited Pfeiffer,s research in biomedical imaging, and in particular ... approach has laid the foundation for applications of this ... to deliver improved image contrast with lower doses of ... from fundamental biophysical investigations to applications in medical imaging ...
Cached Biology News:Personalized diets for elderly after hospitalization decreases mortality rates 2Discovery by UC Riverside entomologists could shrink dengue-spreading mosquito population 2Physicist Franz Pfeiffer receives 2011 Leibniz Prize 2
... SIGNETs BCIP/NBT Chromogen system ... Tetrazolium] chromogen in a single ... reacts in the presence of ... staining with minimal background noise. ...
... BCIP/NBT Chromogen system consists of ... in a single component,solution. The ... the presence of alkaline phosphatase ... with minimal background noise. ,The ...
Mouse monoclonal antibody raised against a partial recombinant VEGFB. NCBI Entrez Gene ID = VEGFB...
... - NH2 is primarily used for the ... cellular proteins for tracing. NH2-Reactive B-Phycoerythrin, a ... (NHS), and can easily make a covalent ... other proteins without any activation process. Filtration ...
Biology Products: